+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Short-term lower leg growth in asthmatic children treated with inhaled beta2-agonists



Short-term lower leg growth in asthmatic children treated with inhaled beta2-agonists



Annals of Human Biology 33(2): 135-141



Background: Knemometry studies of growth suppressive effects of inhaled glucocorticoids in children with asthma usually allow participating children to use concomitant inhaled beta(2)- agonists.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 012554851

Download citation: RISBibTeXText

PMID: 16684688

DOI: 10.1080/03014460500466879


Related references

Long-, intermediate- and short-term growth studies in asthmatic children treated with inhaled glucocorticosteroids. European Respiratory Journal 9(4): 821-827, 1996

Relationship between short term lower leg growth and long term statural growth in asthmatic children treated with budesonide. European Respiratory Journal Supplement 9(23): 294S, 1996

Review: regular inhaled long acting beta2 agonists are associated with better outcomes than short acting beta2 agonists in adults and children with chronic asthma. Evidence-Based Nursing 6(3): 76-76, 2003

Addition of transdermal or inhaled long-acting Beta2-agonists in adult asthmatic patients treated with inhaled corticosteroids: switchover study from tulobuterol patch to salmeterol dry powder inhaler. Journal of Asthma 44(2): 77-81, 2007

Effect of inhaled salmeterol in asthmatic children previously treated with short acting beta-2-agonists A Swiss multicenter study. European Respiratory Journal 8(SUPPL 19): 518S, 1995

Effect of short- and long-acting inhaled beta2-agonists on exhaled nitric oxide in asthmatic patients. European Respiratory Journal 10(7): 1483-1488, 1997

Inhaled anticholinergics and short-acting beta(2)-agonists versus short-acting beta2-agonists alone for children with acute asthma in hospital. Cochrane Database of Systematic Reviews (): Cd010283-Cd010283, 2015

Short-term growth and collagen turnover in asthmatic adolescents treated with the inhaled glucocorticoid budesonide. Steroids 62(10): 659-664, 1997

Linear growth of prepubertal asthmatic children treated with long-term inhaled budesonide. Journal of Allergy & Clinical Immunology 99(1 PART 2): S324, 1997

Is the increase in bronchial responsiveness or FEV1 shortly after cessation of beta2-agonists reflecting a real deterioration of the disease in allergic asthmatic patients? A comparison between short-acting and long-acting beta2-agonists. Respiratory Medicine 96(3): 155-162, 2002

Combined inhaled anticholinergics and short-acting beta2-agonists for initial treatment of acute asthma in children. Paediatric Respiratory Reviews 14(4): 234-235, 2014

Ergogenic effects of inhaled beta2-agonists in non-asthmatic athletes. Endocrinology and Metabolism Clinics of North America 39(1): 75-87, Ix, 2010

The antioxidative-prooxidative balance in children with asthma treated with inhaled corticosteroids and long acting beta2-agonists. Pneumonologia i Alergologia Polska 73(2): 178-181, 2006

Assessment of the relation between short and intermediate term growth in children with asthma treated with inhaled glucocorticoids. Allergy 59(11): 1193-1197, 2004

Superior efficacy of the fluticasone propionate/salmeterol HFA-MDI combination product versus the individual components in asthmatics previously treated with either short- or long-acting beta2-agonists or inhaled corticosteroids. Journal of Allergy & Clinical Immunology 107(2): S102, February, 2001